Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

γ-Secretase inhibitors for breast cancer and hepatocellular carcinoma: From mechanism to treatment
Hui Jia, Zuojun Wang, Jingyi Zhang, et al.
Life Sciences (2021) Vol. 268, pp. 119007-119007
Closed Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Notch signaling in the tumor immune microenvironment of colorectal cancer: mechanisms and therapeutic opportunities
Jiachun Sun, Yi Chen, Ziyi Xu, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Elucidating the Molecular Basis of Sorafenib Resistance in HCC: Current Findings and Future Directions
Francesca Fornari, Catia Giovannini, Fabio Piscaglia, et al.
Journal of Hepatocellular Carcinoma (2021) Vol. Volume 8, pp. 741-757
Open Access | Times Cited: 47
A novel small-molecule antagonist enhances the sensitivity of osteosarcoma to cabozantinib in vitro and in vivo by targeting DNMT-1 correlated with disease severity in human patients
Ji‐Hai Wang, Zhen Zeng, Jie Sun, et al.
Pharmacological Research (2021) Vol. 173, pp. 105869-105869
Closed Access | Times Cited: 33
Inhibition of γ-secretase/Notch pathway as a potential therapy for reversing cancer drug resistance
Mei Feng, Ramesh Kumar Santhanam, Huan Xing, et al.
Biochemical Pharmacology (2023) Vol. 220, pp. 115991-115991
Closed Access | Times Cited: 14
TPX2 enhances the transcription factor activation of PXR and enhances the resistance of hepatocellular carcinoma cells to antitumor drugs
Hongbo Wang, Fang Chu, Xiaofeng Zhang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 12
Single‐cell transcriptomic analysis in clear cell renal cell carcinoma: Deciphering the role of APP within the tumour microenvironment
Bo Guan, Ming O. Li, Di Cui, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 6
Open Access | Times Cited: 4
Notch signaling in cancers: mechanism and potential therapy
Chen Chen, Yan Du, Rong-zu Nie, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Polygonum multiflorum Stilbene Glycoside Oligomers induce the ferroptosis of triple negative breast cancer cells
Xiaomeng Lin, Hua Yang, Tingting Cai, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Breast cancer and its therapeutic targets: A comprehensive review
Ayushi Singh, Rakhi Mishra, Avijit Mazumder
Chemical Biology & Drug Design (2023) Vol. 103, Iss. 1
Closed Access | Times Cited: 8
Review deciphering potent therapeutic approaches targeting Notch signaling pathway in breast cancer
Pratibha Pandey, Fahad Khan, Min Gew Choi, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114938-114938
Open Access | Times Cited: 7
Secretase promotes AD progression: simultaneously cleave Notch and APP
Ke-Fan Yang, Jingyi Zhang, Mei Feng, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 2
MDM2 Binding Protein Induces the Resistance of Hepatocellular Carcinoma Cells to Molecular Targeting Agents via Enhancing the Transcription Factor Activity of the Pregnane X Receptor
Qiyu Jiang, Yan Ma, Jingjing Han, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 16
Novel inhibitor of OCT1 enhances the sensitivity of human esophageal squamous cell carcinoma cells to antitumor agents
Xiao-Zheng Zou, Xiuhua Zhou, Yingqi Feng, et al.
European Journal of Pharmacology (2021) Vol. 907, pp. 174222-174222
Closed Access | Times Cited: 15
Small molecules targeting γ-secretase and their potential biological applications
Jiachen Wen, Dan Liu, Linxiang Zhao
European Journal of Medicinal Chemistry (2022) Vol. 232, pp. 114169-114169
Closed Access | Times Cited: 10
A Novel Small Molecular Inhibitor of DNMT1 Enhances the Antitumor Effect of Radiofrequency Ablation in Lung Squamous Cell Carcinoma Cells
Yuan-Yuan Liu, Chengzhi Ding, Jia-Ling Chen, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 10
Identification of Potential RBPJ-Specific Inhibitors for Blocking Notch Signaling in Breast Cancer Using a Drug Repurposing Strategy
Mengjie Rui, Cai Min, Yu Zhou, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 556-556
Open Access | Times Cited: 10
Cancer stem cells: Signaling pathways and therapeutic targeting
Joyeeta Talukdar, Tryambak Srivastava, Om Saswat Sahoo, et al.
MedComm – Oncology (2023) Vol. 2, Iss. 4
Open Access | Times Cited: 6
Nuclear Mechanisms Involved in Endocrine Resistance
Jürgen Dittmer
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 11
Knockdown of FBI-1 Inhibits the Warburg Effect and Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Molecular Targeted Agents via miR-3692/HIF-1α
Juan Liu, Chao Yang, Xiaomei Huang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 11
Cyclitols: From Basic Understanding to Their Association with Neurodegeneration
Maria Derkaczew, Piotr Martyniuk, Adam Osowski, et al.
Nutrients (2023) Vol. 15, Iss. 9, pp. 2029-2029
Open Access | Times Cited: 4
How mitochondrial dynamics imbalance affects the progression of breast cancer:a mini review
Jingwen Kuang, H. Liu, Linlin Feng, et al.
Medical Oncology (2024) Vol. 41, Iss. 10
Open Access | Times Cited: 1
Activation of the γ-secretase/NICD-PXR/Notch pathway induces Taxol resistance in triple-negative breast cancer
Zuojun Wang, Xiang-Yi Zhan, Liang-Yu Ma, et al.
Biochemical Pharmacology (2024), pp. 116577-116577
Closed Access | Times Cited: 1
Pralatrexate represses the resistance of HCC cells to molecular targeted agents via the miRNA-34a/Notch pathway
Jin Yang, Qiming Liu, Baisheng Sun, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
miR-27-3p Enhances the Sensitivity of Triple-Negative Breast Cancer Cells to the Antitumor Agent Olaparib by Targeting PSEN-1, the Catalytic Subunit of Γ-Secretase
Meng Zhao, Baisheng Sun, Yan Wang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 10
Sulindac sulfide as a non-immune suppressive γ-secretase modulator to target triple-negative breast cancer
Fokhrul Hossain, Deniz A. Uçar, Giulia Monticone, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top